Page 12 - 《中国药房》2023年22期
P. 12
参考文献 status quo of industry development of Kampo medicine in
[ 1 ] 黄红华. 政策工具理论的兴起及其在中国的发展[J]. 社 Japan[J]. Mod Chin Med,2018,20(7):785-790.
会科学,2010(4):13-19,187. [ 9 ] 刘晖晖. 中药配方颗粒的产业竞争力分析与金银花配方
HUANG H H. On emergence of policy instrumentation 颗粒的关键技术示范研究[D]. 广州:广州中医药大学,
theory and its development in China[J]. J Soc Sci,2010 2011.
(4):13-19,187. LIU H H. Study on the industrial competitiveness of con‐
[ 2 ] 陈振明. 加强对公共服务提供机制与方式的研究[J]. 东 centrated herb granule(CHG) and the key technologies of
南学术,2007(2):69-76. CHG of Flos Lonicerae[D]. Guangzhou:Guangzhou
CHEN Z M. Strengthen the research on the mechanism University of Chinese Medicine,2011.
and mode of public service provision[J]. Southeast Acad [10] 温雅心,董玲,杨丽,等. 中药配方颗粒的发展现状及国
Res,2007(2):69-76. 际化对策探讨[J]. 中国现代中药,2021,23(8):1319-
[ 3 ] 王涛,刘书琪,黎耀宏,等 . 中药配方颗粒发展现状及企 1325.
WEN Y X,DONG L,YANG L,et al. Development status
业生存策略探讨[J/OL].中国实验方剂学杂志,2023:1-8
(2023-03-14)[2023-08-22].https://doi.org/10.13422/j.cnki. and internationalization strategies of Chinese medicine
formula granules[J]. Mod Chin Med,2021,23(8):1319-
syfjx.20230746.
1325.
WANG T, LIU S Q, LI Y H, et al. Discussion on deve-
lopment status of traditional Chinese medicine dispensing [11] 孙源源,施萍. 借助中药配方颗粒推进中药国际化的对
策研究[J]. 中草药,2013,44(8):929-934.
granules and survival strategy of enterprises[J]. Chin J
SUN Y Y,SHI P. Countermeasures for promoting interna‐
Exp Tradit Med Form,2023:1-8(2023-03-14)[2023-08-
22].https://doi.org/10.13422/j.cnki.syfjx.20230746. tionalization of Chinese materia medica by virtue of for‐
mula granule[J]. Chin Tradit Herb Drugs,2013,44(8):
[ 4 ] 聂小忠. 中药配方颗粒研发的战略思考[C]//第二届中药
929-934.
配方颗粒研究开发与质量控制技术交流研讨会论文集.
杭州,2016:74-77. [12] 张莹莹,季巧遇,李青 . 中药配方颗粒研究现状[J]. 亚太
传统医药,2018,14(12):94-96.
NIE X Z. Strategic thinking on the research and develop‐
ment of granules formulated with traditional Chinese ZHANG Y Y,JI Q Y,LI Q. Research status of prescrip‐
tion granules of traditional Chinese medicine[J]. Asia Pac
medicine[C]// Proceedings of the 2nd Symposium on
Tradit Med,2018,14(12):94-96.
Research and Development and Quality Control Techno- [13] 《人民日报》健康客户端 . 张伯礼:建议取消中药配方颗
logy Exchange of Chinese Medicine Formula Granules.
粒“省标” 避免重复研究与资源浪费[EB/OL].(2022-03-
Hangzhou,2016:74-77.
09)[2022-10-22].https://m.baidu.com/bh/m/detail/ar_
[ 5 ] ROTHWELL R,ZEGVELD W. Innovation and the small
9660774104809970915.
and medium sized firm[J]. Soc Sci Elect Pub,1982,62
People’s Daily Health Client. Zhang Boli:it is recom‐
(11):3734- 3743.
mended to cancel the “provincial standard” of Chinese
[ 6 ] 邵成雷,李振鹏,路杰,等. 中药配方颗粒研究现状及产 medicine formula granules to avoid duplicate research and
业动态[J]. 药学研究,2022,41(11):760-766.
waste of resources[EB/OL].(2022-03-09)[2022-10-22].
SHAO C L,LI Z P,LU J,et al. Research status and in-
https://m.baidu.com/bh/m/detail/ar_9660774104809970915.
dustry dynamics of Chinese medicine formula granules[J]. [14] 吴远波,张鸿,冷红文,等. 中药配方颗粒政策发展及其
J Pharm Res,2022,41(11):760-766.
质量标准发展概述[J]. 江西化工,2021,37(4):27-30.
[ 7 ] 中国质量新闻网. 四川逢春制药有限公司制售劣药被罚 WU Y B,ZHANG H,LENG H W,et al. Overview of
没 49 万余元[EB/OL].(2022-10-13)[2023-10-22].https:// policy development and quality standard development of
baijiahao. baidu. com/s? id=1746555396389696967&wfr= Chinese medicine dispensing granules[J]. Jiangxi Chem
spider&for=pc&searchword. Ind,2021,37(4):27-30.
China Quality News. Sichuan Fengchun Pharmaceutical [15] 李梅,谭国瑜,黄秋芬,等. 我国中药配方颗粒现状分析
Co.,Ltd. was fined more than 490 000 yuan for the manu‐ [J]. 中国中医药现代远程教育,2022,20(19):47-50.
facture and sale of inferior drugs[EB/OL].(2022-10-13) LI M,TAN G Y,HUANG Q F,et al. Analysis on the pre-
[2023-10-22].https://baijiahao.baidu.com/s?id=1746555- sent situation of Chinese medicine formula granules in
396389696967&wfr=spider&for=pc&searchword. China[J]. Chin Med Mod Distance Educ China,2022,20
[ 8 ] 丁腾,李耿,张红,等. 日本汉方药产业发展现状分析及 (19):47-50.
思考[J]. 中国现代中药,2018,20(7):785-790. (收稿日期:2023-04-13 修回日期:2023-10-27)
DING T,LI G,ZHANG H,et al. Analysis and thought on (编辑:孙 冰)
· 2694 · China Pharmacy 2023 Vol. 34 No. 22 中国药房 2023年第34卷第22期